Study identification

EU PAS number

EUPAS35147

Study ID

35988

Official title and acronym

Real-time systematic review and meta-analysis of non-randomised comparative treatment studies for COVID-19

DARWIN EU® study

No

Study countries

Spain
United Kingdom

Study description

A real-time systematic review and meta-analysis of non-randomised studies to compare in-hospital clinical outcomes in patients managed with standard care and various treatments for COVID-19.To compare the results of treatments in non-randomised comparative studies and randomised controlled trials for in-hospital clinical outcomes in COVID-19 patients.

Study status

Ongoing
Research institutions and networks

Institutions

OXON Epidemiology
Spain
United Kingdom
First published:
15/03/2024
Institution Laboratory/Research/Testing facility Non-Pharmaceutical company ENCePP partner

Contact details

Nawab Qizilbash MRCP MSc DPhil(Oxon)

Primary lead investigator

Study timelines

Date when funding contract was signed

Planned:
Actual:

Study start date

Planned:
Actual:

Date of final study report

Planned:
Sources of funding
Other
Pharmaceutical company and other private sector 

More details on funding

GSK, OXON Epidemiology
Regulatory

Was the study required by a regulatory body?

No

Is the study required by a Risk Management Plan (RMP)?

Not applicable